Diabetes

By Dave Muoio February 5, 2018
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems. "JDRF is excited to partner with Cam Med on improving insulin delivery hardware,” Jaime Giraldo, program...
By Dave Muoio January 4, 2018
An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month. “The cost of a well-controlled diabetes patient will typically range in the $13,000 range [to] $20,000 annually. When you contrast that with the cost of a patient that doesn’t have diabetes, that number is typically...
By Dave Muoio January 4, 2018
Mobile textile company Sensoria Health (an independent strategic partnership between Sensoria Fitness and Genesis Rehab Services) and diabetic mobility garment maker Optima Molliter are collaborating on a smart footwear product capable of measuring diabetes patients’ compliance to prescribed mechanical offloading protocols. “By combining the best innovations in diabetic footwear technology and...
By Laura Lovett November 30, 2017
A recent data analysis by Evidation Health found that by using wearables, researchers could track activity characteristics associated with co-morbid mental health illness symptoms among people with diabetes.  “Individuals with diabetes are at a higher risk of developing mental health illnesses than those without diabetes. This increased risk is partially due to the fact that diabetes is a...
By Dave Muoio November 29, 2017
A slew of digital diabetes care companies have announced integrations with the upcoming virtual Type 2 diabetes management platform being developed by Onduo, a joint venture of Verily and Sanofi. These announced services include Voluntis’ Insulia, a digital insulin dose recommendation and coaching system; Glytec’s Glucommander Outpatient, cloud-based software that evaluates blood glucose and...
By Laura Lovett November 27, 2017
San Diego-based Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $10 million in Series A financing. The round was led by M Ventures, in collaboration with Hikma Ventures.  Biolinq is currently working on a skin applied, minimally-invasive electrochemical biosensor platform for diabetes patients, which analyzes biomarkers in the...
By Jonah Comstock November 16, 2017
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a "digital companion" app for people with Type 2 diabetes. Insulia offers realtime basal insulin dose coaching, and the new clearance makes the app usable with two additional brands of insulin: Basaglar and Tresiba. The app had already worked for users of Lantus,...
By Dave Muoio November 14, 2017
During its Q3 earnings call, Israel-based DarioHealth announced a growing US install base for its smartphone-connected glucometer and increased revenues supported by increasing sales of the platform’s accompanying consumable test strips. While the company expects each of these to take an even larger bite from its cash burn in the coming months, CEO and Chairman Erez Raphael also highlighted...
By Laura Lovett November 10, 2017
A new study reveals that artificial intelligence could be a useful tool to help patients prevent Type 2 diabetes. The study, published in the Journal of Medical Internet Research, showed that patients at risk of Type 2 diabetes who used the Lark Weight Loss Health Coach AI, dropped 2.38 percent of their baseline weight and increase the percentage of healthful meals they ate by 31 percent.  “I’m...
By Jonah Comstock November 2, 2017
On Fitbit’s third quarter earnings call yesterday, the company shared that, between spending cuts and the launch of the its long-awaited smartwatch, the company is pulling out of the earnings slump it’s been experiencing. The call also saw CEO James Park talking more than ever about the fitness wearable’s clinical applications and the ways in which those ambitions are coming to fruition. This...